Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
101.72B | 101.43B | 99.94B | 93.85B | 80.79B | 86.96B | Gross Profit |
15.59B | 15.68B | 15.65B | 15.27B | 14.36B | 10.86B | EBIT |
3.48B | 3.03B | 3.67B | 3.09B | 3.32B | 569.00M | EBITDA |
7.50B | 10.47B | 9.17B | 8.24B | 8.08B | 5.22B | Net Income Common Stockholders |
588.00M | 2.16B | 1.11B | -1.68B | 1.32B | -125.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.14B | 1.76B | 3.11B | 3.71B | 5.06B | 4.25B | Total Assets |
118.11B | 109.95B | 111.54B | 100.11B | 96.92B | 93.89B | Total Debt |
48.43B | 41.15B | 39.78B | 36.70B | 36.15B | 37.44B | Net Debt |
44.29B | 39.39B | 36.67B | 32.99B | 31.09B | 33.19B | Total Liabilities |
79.72B | 71.11B | 70.94B | 67.91B | 65.00B | 65.50B | Stockholders Equity |
37.45B | 37.93B | 39.72B | 31.43B | 31.06B | 27.56B |
Cash Flow | Free Cash Flow | ||||
0.00 | -3.45B | -3.14B | -1.26B | 1.72B | -3.65B | Operating Cash Flow |
0.00 | 1.73B | 2.97B | 4.88B | 5.08B | 318.00M | Investing Cash Flow |
0.00 | -3.13B | -5.05B | -5.44B | -2.37B | -2.88B | Financing Cash Flow |
0.00 | -138.00M | 1.25B | -940.00M | -2.47B | 2.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥8.21B | 2.78 | 3.04% | 2.17% | 66.19% | ||
76 Outperform | ¥9.60B | 4.45 | 5.57% | 1.49% | 93.90% | ||
73 Outperform | ¥9.96B | 5.50 | 3.72% | -4.87% | -19.12% | ||
70 Outperform | ¥8.56B | 6.00 | 7.17% | 0.69% | 7.21% | ||
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
53 Neutral | ¥8.14B | ― | 2.79% | -3.96% | -462.49% | ||
51 Neutral | ¥8.70B | ― | 3.25% | 24.16% | 93.48% |